Authors: Leflein, Jeffrey G.; Gawchik, Sandra M.; Galant, Stanley P.; Lyzell, Ewa; Young, Mike; Cruz-Rivera, Mario; Walton-Bowen, Karen; Smith, Joseph A.; Fitzpatrick, Sherahe

Source: Allergy and Asthma Proceedings, Volume 22, Number 6, November-December 2001 , pp. 359-366(8)

Publisher: OceanSide Publications, Inc

Abstract:

Three open-label extension trials evaluated the safety of budesonide inhalation suspension (BIS; Pulmicort Respules) in 670 children (8 months-9 years of age) with mild-to-severe persistent asthma. Patients were randomized to receive either BIS or conventional asthma therapy (CAT) for 52 weeks. The percentage of patients who discontinued because of clinical adverse events was low and similar among the CAT (0.4%) and BIS (0.7%) groups. After adjusting for length of time in the studies, there were no clinically relevant differences between the BIS and CAT groups in the type, incidence, or intensity of adverse events; vital signs or physical examination outcomes; or changes in clinical laboratory evaluations or oral fungal cultures.

Document Type: Regular paper

Publication date: 2001-11-01

More about this publication?

• Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
  
  The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
  
  Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
  
  The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
• Editorial Board
• Information for Authors
• Submit a Paper
• Information for Advertisers
• Reprint Requests
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Allergy & Immunology
• By this author: Leflein, Jeffrey G. ;  Gawchik, Sandra M. ;  Galant, Stanley P. ;  Lyzell, Ewa ;  Young, Mike ;  Cruz-Rivera, Mario ;  Walton-Bowen, Karen ;  Smith, Joseph A. ;  Fitzpatrick, Sherahe

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers